References
- LaRusso NF, Wiesner RH, Ludwig J, McCarthy RL. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899–903
- Tischendorf JJW, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007; 102: 107–14
- Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121–7
- Tischendorf JJW, Meier PN, Straßburg C, Klempnauer J, Hecker H, Manns MP, et al. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2006; 41: 1227–34
- De Vreede I, Steers J, Burch P, Rosen C, Gunderson L, Haddock M, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309–16
- Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451–61
- Tischendorf JJW, Krüger M, Trautwein C, Duckstein N, Schneider A, Manns MP, et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 2006; 38: 665–9
- Tischendorf JJW, Meier PN, Schneider A, Manns MP, Kruger M. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2007; 42: 1011–17
- Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary cholangitis: a long-tern follow-up study. Scand J Gastroenterol 1987; 22: 655–64
- Stockbrugger RW, Olsson R, Jaup B, Jensen J. Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology 1988; 35: 289–94
- Riegler G, D'Inca R, Sturniolo GC, Corrao G, Del Vecchio BC, Di L, et al. Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto. Scand J Gastroenterol 1998; 33: 93–8
- Hirche TO, Russler J, Braden B, Schuessler G, Zeuzem S, Wehrmann T, et al. Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Coloretal Dis 2004; 19: 586–94
- Johnson KJ, Olliff JF, Olliff SP. The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis. Br J Radiol 1998; 71: 1279–82
- Abu-Elmagd K, Selby R, Iwatsuki S, Fung J, Tzakis A, Tong S, et al. Cholangiocarcinoma and sclerosing cholangitis; clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124–5
- Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994; 20: 33S–40S
- Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF, , et al Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 1997;26:467–72 [ Erratum in Hepatology 1998;28:1444].
- Wedemeyer H, Ockenga J, Frank H, Tillmann HL, Schuler A, Caselitz M, et al. Perihepatic lymphandeopathy: a marker of response to interferon alpha in chronic hepatitis C. Hepatogastroenterology 1998; 45: 1062–8
- Dietrich CF, Stryjek-Kaminska D, Teuber G, Lee J-H, Caspary WF, Zeuzem S. Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. Am J Radiology 2000; 174: 699–704